Literature DB >> 12420153

Effects of haloperidol on cue-induced autonomic and behavioral indices of heroin reward and motivation.

Aaron Ettenberg1, Krista McFarland2.   

Abstract

RATIONALE: Most theoretical conceptions of motivation presume an internal state of sympathetic nervous system activation that precedes and accompanies goal-seeking behavior.
OBJECTIVES: The present study investigates the animals' physiological and behavioral response to presentation of environmental cues predictive of availability (S+) or non-availability (S-) of heroin in the goal box of a straight-arm alley.
METHODS: Animals were trained to discriminate between two olfactory cues, one predictive of the delivery of i.v. heroin (0.1 mg/kg) upon the rat's entry into the goal box of the runway (the S+) and another cue (the S-) predictive of i.v. saline upon goal-box entry. Once discriminative performance had stabilized, animals were challenged with each of four haloperidol treatments in a counterbalanced manner (0.0, 0.075, 0.15, 0.3 mg/kg i.p.). Run times and heart rates (measured via radiotelemetry) served as the dependent variables on every trial.
RESULTS: Both behavioral and physiological measures of motivation responded differentially to S+ and S- cues. Haloperidol had no effect during or immediately following S- trials, nor prior to reinforcer delivery on S+ trials. However, the behavioral and physiological consequences of heroin delivery during dopamine receptor antagonism were reliable - animals ran more slowly and showed less activation (lower heart rates) on the first S+ trial following a heroin + haloperidol experience.
CONCLUSIONS: The current data demonstrate that physiological and behavioral indices of cue-induced motivation remained intact during haloperidol challenge, while the reinforcing consequences of heroin appear to have been attenuated by dopamine receptor antagonism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420153     DOI: 10.1007/s00213-002-1266-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits.

Authors:  G Fouriezos; R A Wise
Journal:  Brain Res       Date:  1976-02-20       Impact factor: 3.252

2.  Naloxone blocks reinforcement but not motivation in an operant runway model of heroin-seeking behavior.

Authors:  K McFarland; A Ettenberg
Journal:  Exp Clin Psychopharmacol       Date:  1998-11       Impact factor: 3.157

3.  Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene.

Authors:  Mary A Raven; Brian D Necessary; Deborah A Danluck; Aaron Ettenberg
Journal:  Exp Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.157

Review 4.  Dopamine receptor pharmacology.

Authors:  P Seeman; H H Van Tol
Journal:  Trends Pharmacol Sci       Date:  1994-07       Impact factor: 14.819

5.  Effects of haloperidol in a response-reinstatement model of heroin relapse.

Authors:  A Ettenberg; L A MacConell; T D Geist
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

6.  Conditioned incentive properties of a food-paired conditioned stimulus remain intact during dopamine receptor blockade.

Authors:  J C Horvitz; A Ettenberg
Journal:  Behav Neurosci       Date:  1991-08       Impact factor: 1.912

7.  Ventrolateral striatal dopamine depletions impair feeding and food handling in rats.

Authors:  J D Salamone; K Mahan; S Rogers
Journal:  Pharmacol Biochem Behav       Date:  1993-03       Impact factor: 3.533

8.  Pimozide blocks reinforcement but not priming from MFB stimulation in the rat.

Authors:  E M Wasserman; Y Gomita; C R Gallistel
Journal:  Pharmacol Biochem Behav       Date:  1982-10       Impact factor: 3.533

9.  Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure.

Authors:  M S Cousins; J D Salamone
Journal:  Pharmacol Biochem Behav       Date:  1994-09       Impact factor: 3.533

10.  Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.

Authors:  R A Wise; J Spindler; H deWit; G J Gerberg
Journal:  Science       Date:  1978-07-21       Impact factor: 47.728

View more
  8 in total

1.  Weakening of negative relative to positive associations with cocaine-paired cues contributes to cue-induced responding after drug removal.

Authors:  Zu-In Su; Gleb Kichaev; Jennifer Wenzel; Osnat Ben-Shahar; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2011-10-08       Impact factor: 3.533

2.  Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.

Authors:  Sandro Fenu; Liliana Spina; Emilia Rivas; Rosanna Longoni; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

3.  Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition.

Authors:  Liliana Spina; Sandro Fenu; Rosanna Longoni; Emilia Rivas; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

4.  Activation of physiological stress responses by a natural reward: Novel vs. repeated sucrose intake.

Authors:  Ann E Egan; Yvonne M Ulrich-Lai
Journal:  Physiol Behav       Date:  2015-03-05

Review 5.  Pleasure systems in the brain.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Neuron       Date:  2015-05-06       Impact factor: 17.173

Review 6.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

Review 7.  The runway model of drug self-administration.

Authors:  Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

Review 8.  Neural regulation of endocrine and autonomic stress responses.

Authors:  Yvonne M Ulrich-Lai; James P Herman
Journal:  Nat Rev Neurosci       Date:  2009-06       Impact factor: 34.870

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.